St. Louis University
slu.eduTotal trials
151
Active
17
Phase 3
2
Total enrollment
12,497
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 17 of 17 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Cefazolin | — | — | — | — | — | 1 | |
| Cephalexin | — | — | — | — | — | 1 | |
| Meloxicam 15 mg | — | — | — | — | — | 1 | |
| Medrol 4 MG Oral Tablet Includes Medrol Dosepak | — | — | — | — | — | 1 | |
| Gabapentin 300 mg | — | — | — | — | — | 1 | |
| Hydrocodone 5Mg/Acetaminophen 325Mg Tab | — | — | — | — | — | 1 | |
| Ketorolac 10 Mg Oral | — | — | — | — | — | 1 | |
| Acetaminophen | — | — | — | — | 3 | ||
| Ketorolac | — | — | — | — | 2 | ||
| Zoledronic Acid | — | — | — | — | — | 1 | |
| Normal saline | — | — | — | — | — | 1 | |
| Oxycodone Acetaminophen | — | — | — | — | — | 1 | |
| Morphine | — | — | — | — | — | 1 | |
| Hydrocodone/Acetaminophen | — | — | — | — | — | 1 | |
| Oxycodone | — | — | — | — | — | 1 | |
| Jatenzo Pill | — | — | — | — | — | 1 | |
| Assessment of the frequency of APOL-1 renal risk variant in the black population, and evaluating their attitudes about genetic testing and APOL1 genotype via self-administered surveys | — | — | — | — | — | 1 |
Next readouts
- 2026-06-30
- 2026-12-31
- 2027-01
- 2028-06
- 2030-09
- 2033-09
Top conditions
- Pregnancy6
- Hypertension5
- Interstitial Cystitis5
- Opioid Use4
- Endometriosis3
- Cutibacterium Acnes2
- Breast Cancer2
- Obesity2
Frequently asked questions about St. Louis University
- How many clinical trials does St. Louis University have on ClinicalTrials.gov?
- St. Louis University is listed as the lead sponsor on 151 clinical trials in ClinicalTrials.gov, 17 of which are currently active (recruiting, enrolling, or ongoing).
- How many of St. Louis University's trials are in Phase 3?
- 2 of St. Louis University's trials are in Phase 3, spread across 17 active drug programs.
- What therapeutic areas does St. Louis University focus on?
- St. Louis University's most-studied conditions on ClinicalTrials.gov are Pregnancy, Hypertension, Interstitial Cystitis, Opioid Use, Endometriosis.
- When are St. Louis University's next clinical trial readouts?
- St. Louis University has 6 upcoming primary-completion readouts tracked here; the soonest is “APOL1 Genetic Testing in African Americans”, expected around 2026-06-30.